Symbols

CVS

CVS Health·NYSE

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 2

Consensus Rating "Strong Buy"

High Cash/net Profit Ratio

Undervalued

RSI Oversold

EPS Below Expectations

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CVS

Cvs Health Corporation

The largest pharmacy chain in the United States

Industry

Consumer Goods Distribution and Retail

Established Date

Listing Date

10/01/1952

Exchange

New York Stock Exchange

Full-time Employees

300,000

Fiscal Year Ends

12-31

Website

www.cvshealth.com

Security Type

Common stock

Office address

One CVS Drive, Woonsocket, Rhode Island, 02895

Business

Prescription drug retail

Introduction

Incorporated in Delaware in 1996, CVS Health Corporation is a leading health solutions company serving consumers through an integrated model that connects healthcare and pharmacy services across the United States. The company operates retail locations, walk-in and primary care medical clinics, and a pharmacy benefits management business serving millions of members. CVS Health also offers health insurance products and related services, including Medicare Advantage and Medicare Part D prescription drug plans. Through its comprehensive approach, the company focuses on expanding personalized, technology-driven care delivery and wellness services to improve access to quality care, enhance health outcomes, and reduce overall healthcare costs. CVS Health operates through four reportable segments: Healthcare Benefits, Health Services, Pharmacy and Consumer Health, and Corporate.

Company Financials

EPS

CVS has released its 2025 Q4 earnings. EPS was reported at 1.09, versus the expected 1, beating expectations. The chart below visualizes how CVS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CVS has released its 2025 Q4 earnings report, with revenue of 105.69B, reflecting a YoY change of 8.17%, and net profit of 2.92B, showing a YoY change of 80.10%. The Sankey diagram below clearly presents CVS's revenue sources and cost distribution.